Template:Cervicitis Urethritis Antibiotics: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
'' | ''Treatment covers both [[gonorrhea]] and [[chlamydia]]'' | ||
====Uncomplicated Infection==== | ====Uncomplicated Infection==== | ||
*[[Ceftriaxone]] 250mg IM once PLUS | *[[Ceftriaxone]] 250mg IM once PLUS | ||
Revision as of 12:30, 31 October 2017
Treatment covers both gonorrhea and chlamydia
Uncomplicated Infection
- Ceftriaxone 250mg IM once PLUS
- Azithromycin 1g PO once OR
- Doxycycline 100mg PO BID x 7 days
Cephalosporin Allergy
- Azithromycin 2g PO once PLUS
- Gentamicin 240mg IM once[1]
- In theory this high dose macrolide will provide treatment for both GC and Chlamydia
Partner treatment
- Cefixime 400mg PO once PLUS
- Azithromycin 1g PO once OR
- Doxycycline 100mg PO BID x 7 days
Associated Bacterial Vaginosis or Trichomonas vaginalis
Non-Pregnant
- Metronidazole 500mg PO BID for 7 days [2]
- Tinidazole 2g PO once
Pregnant
Only treat if the patient is symptomatic
- Metronidazole 500mg PO BID for 7 days [3]
Sexual Partner Treatment
- Female: Same as above
- Male: Metronidazole 2 gm PO x1 [4]
- ↑ CDC: 2015 Sexually Transmitted Diseases Treatment Guidelines
- ↑ Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1–187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1external icon
- ↑ CDC Trichomoniasis 2021. https://www.cdc.gov/std/treatment-guidelines/trichomoniasis.htm
- ↑ Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1–187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1external icon